Posted: 03 Jun 2014 02:00 PM PDT
A
 study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and 
colleagues provides new evidence that metformin, the world's most widely
 used anti-diabetic drug, slows ageing and increases lifespan. In 
experiments reported in the journal Proceedings of the National Academy 
of Sciences, the researchers tease out the mechanism behind metformin's 
age-slowing effects: the drug causes an increase in the number of toxic 
oxygen molecules released in the cell and this, surprisingly, increases 
cell robustness and longevity in the long term.
